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A total of 29 men 60 years and older (mean age 74 years) who complained at least once about nocturnal
voiding and were diagnosed with nocturnal polyuria in the frequency volume chart (FVC) were enrolled in
this study. Body water was measured by bioelectric impedance analysis just after lying down at 4 pm and
after raising legs 30 minutes later. Nocturnal urine production was measured by FVC, and urine production
per unit of time at ﬁrst nocturnal voiding (urine volume at ﬁrst nocturnal voiding/hours of undisturbed sleep
(HUS) : UFN/HUS), urine production per unit of time during sleep (total nocturnal urine volume/hours of
sleep : TNV/HS), etc was evaluated. Extra cellular water (ECW) of 0.19 l (4.0%) in legs was reduced
caused by body position changing. There was a signiﬁcant positive correlation between the amount of ECW
in legs and UFN/HUS, TNV/HS (r＝0.57, p＝0.001 ; r＝0.38, p＝0.042, respectively). Moreover,
UFN/HUS had a signiﬁcant correlation with soft lean mass in legs, ECW in legs and daytime water intake.
This study suggested that a change in leg ﬂuids caused by a change in position results in increased urine
production and decreased HUS.
(Hinyokika Kiyo 62 : 243-248, 2016)
Key words : Nocturia, Bioelectric impedance analysis, HUS (hours undisturbed sleep), Body position
changing, Leg edema
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Table 1. Measurement item in the Frequency
Volume Chart (FVC)
Urine production per unit of time at ﬁrst nocturnal voiding
＝Urine volume at ﬁrst nocturnal voiding/hours of undis-
turbed sleep (HUS)
Urine production per unit of time during sleep
＝Total nocturnal urine volume/hours of sleep
24-h water intake
Daytime water intake (from 6 am to 5 pm)
Table 2. Characteristics of patients in this study
Mean±SD Minimum-Maximum
Age (yo) 73.8± 6.2 (60-84)
Height (cm) 165.3± 6.2 (152-174)
Body weight (kg) 64.4± 9.0 (48-87)
BMI 23.6± 2.9 (17-30)
Prostate volume (ml) 31.1± 14.1 (10-57)
Na (mEq/l) 139.2± 1.7 (134-142)
K (mEq/l) 4.3± 0.3 (4-5)
Cre (mg/dl) 0.9± 0.1 (0.6-1.2)
Blood sugar (mg/dl) 105.1± 27.6 (72-138)
BNP (pg/dl) 36.2± 26.6 (6-88)
Plasma osmolarity (mOs/kg・H2O) 290.4± 4.1 (278-296)
Urine osmolarity (mOs/kg・H2O) 523.7±148.3 (263-839)
Hours of sleep (hr) 8.0± 0.5 (7-9)
Night time frequency 2.7± 1.2 (1-5)
Nocturnal urine volume (ml) 757.5±331.0 (370-2,000)
Hours of undisturbed sleep (hr) 2.7± 1.4 (1-6)
24 h water intake (ml) 1,482± 417 (930-2,250)
Daytime water intake (ml) 1,208± 465 (600-2,200)





















た．今回計測したパラメーターを Table 1 に示す．
統計学手法としては， 2群間の相関は Spearman の
順位相関を用い，就眠後第一排尿時単位尿産生量と就
眠後第一排尿以降の単位尿産生量の差の検定は，







cellular water ; ICW）は平均 21.2 l，細胞外液量（extra
cellular water ; ECW）は 13.5 l であった．部位別水分
量は，上肢 3.7 l（ICW 2.3 l，ECW 1.4 l），体幹 16.0
l（ICW 9.8 l，ECW 6.3 l），下肢 12.2 l（ICW 7.4 l，
ECW 4.8 l）であった．
体位変換による部位別水分変化量をみると，上肢で
は 0.08 l（2.1％）の増加がみられ，それぞれ ICW
0.05 l（2.1％），ECW 0.03 l（2.1％）の増加がみられ
た．体幹では 0.26 l（1.6％）の増加がみられ，それ
ぞれ ICW 0.2 l（2.0％），ECW 0.07 l（1.1％）の増加
がみられた．下肢では 0.26 l（2.1％）の減少がみら
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Table 3. Results of body water distribution
At 4 pm Change after raising legs in 30 minutes
Mean±SD Minimum-Maximum Mean±SD Minimum-Maximum
ICW (l) 21.2±2.3 (16.9-25.9) −0.01±0.64 (−1.1-1.7)
ECW (l) 13.5±1.5 (10.6-16.5) 0.23±0.38 (−0.2-1.4)
Body water (l) 34.7±3.8 (27.5-42.4) 0.22±0.97 (−1.3-2.5)
Segmental Water (l)
Arms 3.7±0.6 (2.8-5.0) −0.08±0.07 (−0.2-0.09)
Trunk 16.0±1.8 (13.0-19.9) −0.26±0.18 (−0.6-0)
Legs 12.2±1.8 (8.9-16.1) 0.26±0.43 (−0.59-1.17)
Segmental ICW (l)
Arms 2.3±0.4 (1.8-3.1) −0.05±0.05 (−0.14-0.06)
Trunk 9.8±1.1 (8.0-12.2) −0.20±0.12 (−0.5-0)
Legs 7.4±1.1 (5.4-9.6) 0.07±0.31 (−0.76-0.64)
Segmental ECW (l)
Arms 1.4±0.2 (1.1-1.9) −0.03±0.02 (−0.06-0.03)
Trunk 6.2±0.7 (5.0-7.7) −0.07±0.11 (−0.3-0.1)
Legs 4.8±0.7 (3.5-6.5) 0.19±0.17 (−0.12-0.75)
Protein (kg) 9.2±1.0 (7.3-11.1)
Mineral (kg) 3.1±0.4 (2.4-3.8)
Body fat mass (kg) 17.5±6.0 (5.7-30.1)
Soft lean mass (kg) 44.4±4.9 (35.2-54.3)




Fat free mass (kg) 47.0±5.1 (37.2-57.3)
泌62,05,02-1
Fig. 1. Change in ECW in legs had a signiﬁcant positive correlation with urine







（r＝0.57，p＝0.001 ; Fig. 1），また総就眠時間単位尿
産生量と下肢細胞外液変化量との間にも有意な正の相
関を認めた（r＝0.38，p＝0.042 ; Fig. 2）．
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Fig. 2. Change in ECW in legs had a signiﬁcant positive correlation with urine
production per unit of time during sleep (TNV/HS) (r＝0.38, p＝0.042).
Table 4. Variables correlated with UFN/HUS and





Soft lean mass in legs 0.4 0.034
Plasma osmolarity −0.34 0.068
Cre/Soft lean mass −0.54 0.002
BNP ＜0.01 0.996
Blood sugar 0.16 0.407
ECW in trunk 0.05 0.806
ECW in legs 0.4 0.032
24 h drinking volume 0.39 0.049
Daytime drinking volume 0.44 0.024






































































高い evidence level を有し14~16)，夜間多尿による夜間
頻尿に対し，夜間排尿回数の減少作用ならびに，
HUS の延長を来たし患者 QOL の向上を来たしてい
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